Overall, these data based on using non-targeting kinase inhibitors illustrate that potent synergy scores observed for FGFR and VEGFR inhibitors in GIST T-1R cells were solely due to the inhibition of overactivated FGFR and VEGFR signaling pathways. This evidence concerns the gene KDR and gastrointestinal stromal tumor.